Prencipe, B.; Delprete, C.; Garolla, E.; Corallo, F.; Gravina, M.; Natalicchio, M.I.; Buongiorno, D.; Bevilacqua, V.; Altini, N.; Brunetti, A.
An Explainable Radiogenomic Framework to Predict Mutational Status of KRAS and EGFR in Lung Adenocarcinoma Patients. Bioengineering 2023, 10, 747.
https://doi.org/10.3390/bioengineering10070747
AMA Style
Prencipe B, Delprete C, Garolla E, Corallo F, Gravina M, Natalicchio MI, Buongiorno D, Bevilacqua V, Altini N, Brunetti A.
An Explainable Radiogenomic Framework to Predict Mutational Status of KRAS and EGFR in Lung Adenocarcinoma Patients. Bioengineering. 2023; 10(7):747.
https://doi.org/10.3390/bioengineering10070747
Chicago/Turabian Style
Prencipe, Berardino, Claudia Delprete, Emilio Garolla, Fabio Corallo, Matteo Gravina, Maria Iole Natalicchio, Domenico Buongiorno, Vitoantonio Bevilacqua, Nicola Altini, and Antonio Brunetti.
2023. "An Explainable Radiogenomic Framework to Predict Mutational Status of KRAS and EGFR in Lung Adenocarcinoma Patients" Bioengineering 10, no. 7: 747.
https://doi.org/10.3390/bioengineering10070747
APA Style
Prencipe, B., Delprete, C., Garolla, E., Corallo, F., Gravina, M., Natalicchio, M. I., Buongiorno, D., Bevilacqua, V., Altini, N., & Brunetti, A.
(2023). An Explainable Radiogenomic Framework to Predict Mutational Status of KRAS and EGFR in Lung Adenocarcinoma Patients. Bioengineering, 10(7), 747.
https://doi.org/10.3390/bioengineering10070747
